U.S. to Launch Long COVID Trial Focused on Sleep, Exercise

Long COVID has never been the kind of health problem that politely waits its turn. For millions of Americans, it has barged into daily life with a suitcase full of symptoms: crushing fatigue, brain fog, sleep problems, shortness of breath, racing heartbeats, and the especially sneaky villain known as post-exertional malaise. That last one sounds like a fancy phrase from a medical textbook, but patients know it in very real terms: you do the laundry, answer emails, take a short walk, or sit through a social event, and then your body hits the “nope” button for hours, days, or even weeks.

Now, U.S. researchers are focusing on two of the most frustrating and life-limiting parts of Long COVID: disrupted sleep and difficulty tolerating activity. Through the National Institutes of Health’s RECOVER Initiative, new clinical trials are studying whether targeted treatments can help people sleep better, manage daytime sleepiness, improve exercise intolerance, and reduce post-exertional crashes.

The trials are important because Long COVID treatment has often felt like assembling furniture without instructions: everyone has tools, nobody agrees which screw goes where, and the patient is exhausted before step two. By testing specific interventions in organized clinical trials, researchers hope to move from guesswork to evidence.

What Is the New U.S. Long COVID Trial About?

The new trial effort is part of RECOVER, short for Researching COVID to Enhance Recovery. RECOVER is a large federal research program created to understand, prevent, and treat Long COVID, also called post-acute sequelae of SARS-CoV-2 infection, or PASC.

The newly launched studies focus on two major trial groups: RECOVER-SLEEP and RECOVER-ENERGIZE. Together, they examine some of the most common symptoms reported by people living with Long COVID: sleep disturbances, hypersomnia, poor sleep quality, exercise intolerance, and post-exertional malaise.

RECOVER-SLEEP is designed for adults whose sleep changed after COVID-19. That may mean trouble falling asleep, waking up often, poor sleep quality, an irregular sleep-wake schedule, or feeling extremely sleepy during the day even after what should have been enough rest.

RECOVER-ENERGIZE is aimed at adults whose energy systems seem to have gone on strike after COVID. Some participants experience exercise intolerance, meaning shortness of breath, muscle weakness, or extreme tiredness that forces them to stop activity. Others experience post-exertional malaise, where symptoms get worse after physical, mental, social, or emotional effort.

Why Sleep and Exercise Matter So Much in Long COVID

Sleep and activity are not “small” symptoms. They are the operating system of daily life. When sleep breaks down, everything else becomes harder: concentration, mood, immune regulation, pain tolerance, school, work, parenting, and basic decision-making. When activity tolerance disappears, the world gets smaller. A grocery trip becomes a strategy session. A shower becomes a workout. A birthday party becomes a risk calculation.

Long COVID patients frequently report that symptoms do not fit the usual “just rest and try again tomorrow” pattern. Some people feel worse after pushing themselves. For that group, conventional exercise advice can backfire. This is why the RECOVER-ENERGIZE trials separate participants with post-exertional malaise from those with exercise intolerance but without PEM. That distinction matters. It is the difference between asking, “How can we rebuild capacity safely?” and asking, “How can we prevent crashes in the first place?”

Inside RECOVER-SLEEP: Testing Sleep-Focused Treatments

RECOVER-SLEEP includes two main clinical trials. The first focuses on hypersomnia, or excessive daytime sleepiness. Researchers are testing wake-promoting medications, including modafinil and solriamfetol. These drugs are already approved by the U.S. Food and Drug Administration for certain sleep-related conditions, but they have not been widely studied as treatments for Long COVID-related sleepiness.

In plain English: these medications are not being treated as magic beans. Researchers want to know whether they can safely and meaningfully improve wakefulness in people whose Long COVID symptoms include heavy daytime sleepiness.

The second RECOVER-SLEEP trial focuses on complex sleep disturbances, including poor sleep quality and trouble falling or staying asleep. This study examines melatonin and light therapy. Melatonin is commonly used to help regulate sleep timing, while carefully timed light exposure can help reset the body’s circadian rhythm. Anyone who has ever flown across time zones knows the circadian system can be dramatic. Long COVID may turn that drama into a recurring series.

Participants in RECOVER-SLEEP may be asked to use sleep diaries, wear activity trackers, complete surveys, visit study clinics, and undergo tests related to sleep, thinking, and overall function. This kind of tracking helps researchers measure more than “I feel better” or “I feel worse.” It allows them to compare patterns across participants and study groups.

Inside RECOVER-ENERGIZE: Exercise Intolerance and PEM

RECOVER-ENERGIZE includes two separate trials. One studies personalized cardiopulmonary rehabilitation for participants with exercise intolerance who do not have post-exertional malaise. The program may include exercise training, strength and flexibility work, education, and social support, all tailored to the participant’s condition.

The other trial studies structured pacing for participants with post-exertional malaise. Structured pacing is not the same as “be lazy,” despite what the world’s least helpful motivational poster might suggest. Pacing is a strategy for managing energy, recognizing early warning signs, avoiding overexertion, and stabilizing daily functioning.

The PEM-focused trial is especially notable because participants with PEM are not placed into exercise-training activities that could worsen symptoms. Instead, the study tests whether coaching and structured activity management can help people reduce crashes and improve quality of life.

Why Post-Exertional Malaise Deserves Special Attention

Post-exertional malaise is one of the most misunderstood Long COVID symptoms. It can be triggered by physical activity, but also by mental effort, emotional stress, social interaction, or sensory overload. A person might look fine during the activity and then deteriorate later. That delay can make PEM hard for friends, employers, schools, and even clinicians to understand.

For example, someone may attend a short meeting on Monday and appear completely normal. By Tuesday, they may be stuck in bed with severe fatigue, headache, dizziness, sleep disruption, muscle aches, and brain fog. To outside observers, the connection may seem invisible. To the patient, it is painfully obvious.

This is why Long COVID research needs careful trial design. If a study treats all fatigue as the same, it may miss the subgroup of patients who worsen with exertion. RECOVER-ENERGIZE attempts to avoid that mistake by screening for PEM and assigning participants to different study paths.

How the Trials Could Change Long COVID Care

The best-case scenario is not that one trial suddenly solves Long COVID. That would be wonderful, but chronic illnesses rarely behave like movie villains who disappear after one dramatic final scene. A more realistic and still valuable outcome is that researchers identify which treatments help which symptoms in which patients.

That matters because Long COVID is not one simple condition. The CDC describes it as a serious chronic condition that can last months or years and may involve many body systems. Symptoms can include fatigue, sleep problems, shortness of breath, chest pain, dizziness, digestive issues, headaches, palpitations, mood changes, and cognitive difficulties. Some patients improve over time. Others experience relapses, plateaus, or shifting symptoms.

If RECOVER-SLEEP shows that a treatment improves daytime wakefulness or sleep timing, clinicians may gain a clearer path for patients with those specific symptoms. If RECOVER-ENERGIZE shows that pacing reduces PEM-related crashes, that could strengthen guidance for patients who are currently told to “just exercise more,” even when that advice makes them worse.

What Patients Should Know Before Getting Excited

Clinical trials are hopeful, but they are not guarantees. A treatment can sound promising and still fail to outperform placebo or usual care. That is exactly why trials are necessary. Medicine needs receipts.

Patients should also remember that repurposed drugs can still have side effects and are not automatically appropriate for everyone. Modafinil and solriamfetol may be useful for certain sleep-wake conditions, but they require medical supervision. Melatonin and light therapy may seem simple, yet timing, dosage, sleep disorders, medication interactions, and underlying conditions still matter.

For exercise-related symptoms, the most important message is caution. People with PEM should not assume that graded exercise or aggressive conditioning is safe for them. The RECOVER-ENERGIZE design reflects a growing recognition that PEM is different from ordinary deconditioning.

Why These Trials Took Time

Many Long COVID patients have criticized the slow pace of treatment research, and frankly, their impatience is understandable. When your life has been reduced to half a battery and the charger is missing, “more data soon” can sound like a decorative sentence.

Still, designing Long COVID trials is complicated. Researchers must account for different symptom clusters, prior infections, vaccination status, reinfections, overlapping conditions, medication use, disability levels, and patient safety. They also need diverse participants so results apply to more than one narrow group.

The National Academies’ 2024 definition describes Long COVID as an infection-associated chronic condition that appears after SARS-CoV-2 infection and lasts at least three months. That definition helps standardize research, but the condition itself remains complex. A single trial cannot capture every patient experience. Several carefully designed trials, however, can begin building a usable map.

Specific Examples: What Trial Participation May Look Like

A participant in the RECOVER-SLEEP hypersomnia study might be someone who sleeps eight or nine hours but still feels like their brain is wrapped in a weighted blanket by noon. They may be randomly assigned to a wake-promoting drug or placebo and followed for several weeks while researchers track alertness, symptoms, and safety.

A participant in the complex sleep disturbance study might have trouble falling asleep until 3 a.m., wake repeatedly, and feel unrefreshed. They may use melatonin, timed light exposure, placebo, or a comparison version of the intervention while maintaining a sleep diary.

A participant in the exercise intolerance rehabilitation study might become short of breath or weak after mild activity but not experience delayed PEM crashes. Their program may focus on carefully supervised rebuilding of cardiopulmonary function.

A participant in the structured pacing study might be able to do an errand today but pay for it tomorrow. Their program may involve identifying energy limits, planning rest, reducing boom-and-bust cycles, and learning how to spot early signs of overexertion.

What This Means for Doctors and Clinics

For clinicians, these trials reinforce a practical message: Long COVID care should be symptom-specific and patient-centered. Asking “Do you feel tired?” is not enough. Better questions include: Do symptoms worsen after activity? How long does recovery take? Is sleep refreshing? Do you feel sleepy during the day? Do you wake up often? Do you experience dizziness, palpitations, breathlessness, or cognitive crashes?

Doctors may also need to screen for conditions that can overlap with or worsen Long COVID symptoms, such as sleep apnea, anemia, thyroid disease, asthma, heart rhythm problems, depression, anxiety, migraine, dysautonomia, and medication side effects. Long COVID does not prevent other conditions from existing. The body, unfortunately, is not always considerate enough to have only one problem at a time.

What This Means for Employers, Schools, and Families

The trials also carry a broader social message: Long COVID symptoms are real even when they are invisible. A person who needs flexible hours, remote work, reduced course loads, mobility aids, rest breaks, or quiet recovery time is not being dramatic. They may be managing a condition that punishes overexertion.

Families can help by believing patients, reducing pressure to “push through,” and supporting pacing strategies. Employers and schools can help by focusing on function rather than appearances. Someone may look healthy on a video call and still need accommodations to avoid a crash later.

Experience-Based Perspective: Living With Long COVID Sleep and Activity Limits

For many people with Long COVID, the hardest part is not one symptom; it is the negotiation with everyday life. Sleep becomes unpredictable. Energy becomes a budget tighter than a college student’s grocery list. Plans become conditional: “I can come if I slept,” “I can help if I do nothing tomorrow,” or “I can try, but I may disappear for two days afterward.”

A common experience is the boom-and-bust cycle. On a better day, a person tries to catch up: dishes, emails, laundry, a walk, maybe even a social visit. It feels good to be productive again. Then the crash arrives. The next day, the body feels heavy, the brain feels foggy, and sleep may be either impossible or endless. After enough cycles, patients learn that “feeling okay” does not always mean “safe to do everything.” That lesson can be emotionally difficult because it forces people to slow down before they feel fully stopped.

Sleep problems add another layer. Some Long COVID patients describe being exhausted but wired, as if the body forgot how to power down. Others sleep long hours and wake up unrefreshed, like a phone that spent all night plugged in but somehow reached only 12 percent. Poor sleep can magnify pain, worsen concentration, and make pacing harder because the day begins with less reserve.

Structured pacing can feel awkward at first because it requires planning around limits instead of wishes. A person may divide chores into smaller pieces, sit while preparing food, schedule rest before and after appointments, use mobility support in large stores, or track heart rate and symptoms. None of this is glamorous. Nobody puts “successfully took a shower without triggering a crash” on a motivational calendar. Yet for patients, these small wins can matter deeply.

Families often need time to understand the difference between encouragement and pressure. “You can do it!” sounds supportive, but for someone with PEM, the better phrase may be, “How can we make this easier on your body?” Friends can help by offering flexible plans, shorter visits, quiet hangouts, or no-guilt cancellations. The best support is often practical, calm, and free of speeches about willpower.

Clinicians, too, can make a major difference by validating the pattern. A patient who says, “I get worse after activity” needs careful listening, not a reflexive lecture about exercise. That does not mean movement is never useful. It means the right approach depends on the patient’s symptom profile. For some, supervised rehabilitation may help. For others, especially those with PEM, pacing may be the safer starting point.

This is why the U.S. Long COVID trials focused on sleep and exercise are so meaningful. They reflect what patients have been saying for years: sleep disruption and exertion-related crashes are not side notes. They are central problems that shape daily survival. Testing treatments in a rigorous way will not erase the hardship overnight, but it may give patients and clinicians something better than guesswork.

Conclusion: A Practical Step Toward Better Long COVID Answers

The U.S. launch of Long COVID trials focused on sleep and exercise is a significant step in turning patient experience into testable science. RECOVER-SLEEP will examine treatments for hypersomnia and complex sleep disturbances, including wake-promoting medications, melatonin, and light therapy. RECOVER-ENERGIZE will study personalized cardiopulmonary rehabilitation for exercise intolerance and structured pacing for post-exertional malaise.

The most encouraging part is not just the list of treatments. It is the recognition that Long COVID is not one-size-fits-all. Patients with daytime sleepiness may need different support from those with insomnia. Patients with exercise intolerance may need different care from those with PEM. By studying these groups more carefully, researchers may help build a future where Long COVID care is more precise, more humane, and far less dependent on trial and error.

For now, the message is cautiously hopeful: the science is catching up to the lived experience. It may not be moving as fast as patients deserve, but it is moving in a direction that finally takes sleep, energy, pacing, and post-exertional crashes seriously.